ID WM1799 AC CVCL_A341 SY WM-1799; WM 1799 DR ArrayExpress; E-MTAB-2770 DR BioGRID_ORCS_Cell_line; 690 DR BioSample; SAMN10987990 DR cancercelllines; CVCL_A341 DR Cell_Model_Passport; SIDM01398 DR Cosmic; 888851 DR Cosmic; 1155560 DR Cosmic; 1303067 DR DepMap; ACH-000661 DR GEO; GSM109032 DR GEO; GSM186477 DR GEO; GSM186478 DR GEO; GSM887736 DR GEO; GSM888831 DR IARC_TP53; 30187 DR LiGeA; CCLE_808 DR PharmacoDB; WM1799_1669_2019 DR Progenetix; CVCL_A341 DR Rockland; WM1799-01-0001 DR Wikidata; Q54994197 RX PubMed=15009714; RX PubMed=16827748; RX PubMed=18632627; RX PubMed=22460905; RX PubMed=26589293; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31978347; WW Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: Wistar Institute melanoma cell line collection. CC Population: Caucasian. CC HLA typing: A*26:01,26:01; B*38:01,44:02; C*12:03,12:03; DQA1*01:02,03:02; DQB1*03:02,06:11; DRB1*04:02,15:01 (PubMed=26589293). CC Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar). CC Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=15009714; DepMap=ACH-000661; Wistar). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.37%; Native American=0%; East Asian, North=4.29%; East Asian, South=0%; South Asian=2.08%; European, North=47.56%; European, South=45.7% (PubMed=30894373). CC Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X->X,Y. CC Derived from site: Metastatic; Not specified. ST Source(s): Wistar ST Amelogenin: X,Y ST CSF1PO: 11 ST D13S317: 11,12 ST D16S539: 11 ST D18S51: 13,16 ST D19S433: 16,16.2 ST D21S11: 30 ST D2S1338: 18 ST D3S1358: 14,15 ST D5S818: 11 ST D7S820: 9 ST D8S1179: 12,14 ST FGA: 19,24 ST TH01: 9.3 ST TPOX: 8 ST vWA: 14,17 DI NCIt; C3224; Melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG Age unspecified CA Cancer cell line DT Created: 06-06-12; Last updated: 14-08-25; Version: 33 // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=18632627; DOI=10.1158/0008-5472.CAN-08-0235; PMCID=PMC2615688; RA Smalley, Keiran S.M. RA Contractor, Rooha RA Nguyen, Thiennga K. RA Xiao, Min RA Edwards, Robin RA Muthusamy, Viswanathan RA King, Alastair J. RA Flaherty, Keith Thomas RA Bosenberg, Marcus W. RA Herlyn, Meenhard RA Nathanson, Katherine L. RT "Identification of a novel subgroup of melanomas with RT KIT/cyclin-dependent kinase-4 overexpression."; RL Cancer Res. 68:5743-5752(2008). // RX PubMed=15009714; DOI=10.1046/j.0022-202X.2004.22243.x; PMCID=PMC2586668; RA Tsao, Hensin RA Goel, Vikas RA Wu, Heng RA Yang, Guang RA Haluska, Frank G. RT "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 RT inactivation in melanoma."; RL J. Invest. Dermatol. 122:337-341(2004). // RX PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254; RA Nusinow, David Paul RA Szpyt, John RA Ghandi, Mahmoud RA Rose, Christopher M. RA McDonald, E. Robert 3rd RA Kalocsay, Marian RA Jane-Valbuena, Judit RA Gelfand, Ellen T. RA Schweppe, Devin Karl RA Jedrychowski, Mark P. RA Golji, Javad RA Porter, Dale A. RA Rejtar, Tomas RA Wang, Y. Karen RA Kryukov, Gregory V. RA Stegmeier, Frank RA Erickson, Brian K. RA Garraway, Levi Alexander RA Sellers, William Raj RA Gygi, Steven P. RT "Quantitative proteomics of the Cancer Cell Line Encyclopedia."; RL Cell 180:387-402.e16(2020). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=16827748; DOI=10.1111/j.1600-0749.2006.00322.x; RA Hoek, Keith S. RA Schlegel, Natalie C. RA Brafford, Patricia RA Sucker, Antje RA Ugurel, Selma RA Kumar, Rajiv RA Weber, Barbara L. RA Nathanson, Katherine L. RA Phillips, Donald J. RA Herlyn, Meenhard RA Schadendorf, Dirk RA Dummer, Reinhard RT "Metastatic potential of melanomas defined by specific gene expression RT profiles with no BRAF signature."; RL Pigment Cell Res. 19:290-302(2006). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). //